About: Bharat Aggarwal     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikidata:Q901, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/c/3W2xQbUous

Bharat B. Aggarwal is an Indian-American biochemist. His research has been in the areas of cytokines, the role of inflammation in cancer, and the anti-cancer effects of spices and herbs, particularly curcumin (a chemical constituent of the spice turmeric). He was a professor in the Department of Clinical Immunology, Bioimmunotherapy, and Experimental Therapeutics at University of Texas MD Anderson Cancer Center in Houston, Texas. As of 2022, 30 papers published by Aggarwal have been retracted, ten others have received an expression of concern, and 17 others have been corrected.

AttributesValues
rdf:type
rdfs:label
  • Bharat Aggarwal (en)
rdfs:comment
  • Bharat B. Aggarwal is an Indian-American biochemist. His research has been in the areas of cytokines, the role of inflammation in cancer, and the anti-cancer effects of spices and herbs, particularly curcumin (a chemical constituent of the spice turmeric). He was a professor in the Department of Clinical Immunology, Bioimmunotherapy, and Experimental Therapeutics at University of Texas MD Anderson Cancer Center in Houston, Texas. As of 2022, 30 papers published by Aggarwal have been retracted, ten others have received an expression of concern, and 17 others have been corrected. (en)
foaf:name
  • Bharat B. Aggarwal (en)
name
  • Bharat B. Aggarwal (en)
dct:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
workplaces
dbp:wikiPageUsesTemplate
alma mater
fields
has abstract
  • Bharat B. Aggarwal is an Indian-American biochemist. His research has been in the areas of cytokines, the role of inflammation in cancer, and the anti-cancer effects of spices and herbs, particularly curcumin (a chemical constituent of the spice turmeric). He was a professor in the Department of Clinical Immunology, Bioimmunotherapy, and Experimental Therapeutics at University of Texas MD Anderson Cancer Center in Houston, Texas. In 2012, MD Anderson launched a review of Aggarwal's research after the federal government notified them of allegations of fraud by academic whistleblowers in as many as 65 of Aggarwal's published papers, with the allegations involving images that had been reused and manipulated to represent different results. He retired at the end of 2015; his departure was not made public until February 2016. As of 2022, 30 papers published by Aggarwal have been retracted, ten others have received an expression of concern, and 17 others have been corrected. (en)
institution
gold:hypernym
prov:wasDerivedFrom
page length (characters) of wiki page
academic discipline
Faceted Search & Find service v1.17_git147 as of Sep 06 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3331 as of Sep 2 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 50 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software